RESUMEN
Vários estudos sugerem a importância da vitamina D 25(OH)D na evolução clínica dos pacientes com malária. Entretanto, a prevalência de deficiência de 25(OH)D na população amazônica é pouco conhecida, havendo também poucos estudos com pacientes diagnosticados com malária. Assim, o objetivo deste estudo foi avaliar os níveis séricos de 25(OH)D em pacientes com malária e sua relação com dados epidemiológicos, parasitológico e provas de função hepática. Para tanto, foi realizado um estudo transversal analítico com um grupo de pacientes com malária e um grupo controle no município de Itaituba (PA), Brasil, no período de janeiro de 2018 a outubro de 2019. Elaborou-se um protocolo para avaliação dos dados sociodemográficos, parasitológicos e laboratoriais, adotando-se o nível de significância de 5%. A prevalência de deficiência de 25(OH)D foi observada nos pacientes com malária (28,5%) e no grupo controle (24,6%), sem diferença estatística; porém, entre os residentes no garimpo, os níveis séricos foram estatisticamente menores nos pacientes com malária. Os níveis séricos de transaminase glutâmico-pirúvica (TGP) apresentaram correlação inversa com os de 25(OH)D. As provas de função hepática foram significativamente maiores no grupo com malária. Dessa forma, este estudo evidenciou a deficiência de 25(OH)D em Itaituba. Alterações hepáticas pela infecção plasmodial podem ter contribuído para a correlação inversa observada entre os níveis de TGP e 25(OH)D.
Several studies suggest the importance of vitamin D 25(OH)D in the clinical evolution of patients with malaria. However, the prevalence of 25(OH)D deficiency in the Amazonian population is little known, and studies with patients diagnosed with malaria are scarce. Thus the objective of this study is to evaluate the serum levels of 25(OH)D in patients with malaria and its relationship with epidemiological and parasitological data and liver function tests. To that end, an analytical cross-sectional study was carried out with a group of patients with malaria and a control group in the municipality of Itaituba (PA), Brazil, from January 2018 to October 2019. A protocol was elaborated for the evaluation of sociodemographic, parasitological, and laboratory data, adopting a significance level of 5%. Results: The prevalence of 25(OH)D deficiency was observed in patients with malaria (28.5%) and in the control group (24.6%), with no statistical difference; however, among residents in the mining, serum levels were statistically lower in patients with malaria. The glutamic-pyruvic transaminase (GPT) serum levels showed an inverse correlation with 25(OH)D levels. Liver function tests were significantly higher in the malaria group. Thus, this study evidenced 25(OH)D deficiency in Itaituba. Hepatic changes due to plasmodial infection may have contributed to the inverse correlation observed between GPT and 25(OH)D levels.
Diversos estudios sugieren la importancia de la vitamina D [25(OH)D] en la evolución clínica de pacientes con malaria. Sin embargo, la prevalencia de la deficiencia de 25(OH)D en la población amazónica es poco conocida y existen pocos estudios en pacientes con malaria. Ante esto, el objetivo de este estudio fue evaluar los niveles séricos de 25(OH)D en pacientes con malaria y su relación con datos epidemiológicos, parasitológicos y pruebas de función hepática. Para ello, se realizó un estudio transversal analítico en el grupo de pacientes con malaria y en un grupo control en el municipio de Itaituba (PA), Brasil, de enero de 2018 a octubre de 2019. Se elaboró un protocolo para la evaluación de datos sociodemográficos, parasitológicos y de laboratorio, adoptando un nivel de significancia del 5%. La prevalencia de deficiencia de 25(OH)D se observó en pacientes con malaria (28,5%) y en el grupo control (24,6%), sin diferencia estadística; sin embargo, entre los residentes en la minería, los niveles séricos fueron estadísticamente inferiores en pacientes con malaria. Los niveles séricos de transaminasa glutámico pirúvica (TGP) mostraron una correlación inversa con los niveles de 25(OH)D. Las pruebas de función hepática fueron significativamente más altas en el grupo de malaria. De esta manera, se evidenció deficiencia de 25(OH)D en la población de Itaituba. Los cambios hepáticos debido a la infección plasmodial pueden haber contribuido a la correlación inversa observada entre los niveles de TGP y 25(OH)D.
Asunto(s)
Vitamina D , Pruebas de Función Hepática , MalariaRESUMEN
BACKGROUND: Some studies have suggested the importance of vitamin D [25(OH)D] in malaria clinical practice. The prevalence of 25(OH)D deficiency in the Amazon population is not well known, and there are few studies in patients with malaria. This study aimed to evaluate 25(OH)D serum levels in patients with malaria and determine their relationships with epidemiological, clinical, laboratory, and parasitemia data. METHODS: An analytical cross-sectional study of 123 patients with malaria and 122 individuals without malaria was performed in Itaituba, Pará, Brazil, from January 2018 to October 2019, by evaluating sociodemographic, clinical-epidemiological, parasitological, and laboratory data and adopting a 5% significance level. Parametric tests (Student's t-test), non-parametric tests (Mann-Whitney U), and Spearman's correlation ([rs], for non-parametric variables) were used according to the nature of the distribution of the variables. For the qualitative variables, Pearson's chi-square test, Fisher's exact test, and the G test were used. Spearman's correlation was used to compare the results of the 25(OH)D levels and blood counts performed among patients and the control group. RESULTS: Malaria patients residing in a mining area had 25(OH)D serum levels that were significantly lower than those in the control group residing in the mining area, though both were within normal levels. Red blood cell counts had an inverse correlation with parasitemia (Plasmodium falciparum), and platelet levels had an inverse correlation with parasitemia (Plasmodium vivax). 25(OH)D deficiency was evidenced in Itaituba, in the state of Pará, which is an endemic area of malaria in the Amazon region.
Asunto(s)
Malaria Falciparum , Malaria Vivax , Malaria , Brasil/epidemiología , Estudios Transversales , Humanos , Malaria/epidemiología , Malaria Falciparum/diagnóstico , Malaria Falciparum/epidemiología , Malaria Vivax/diagnóstico , Malaria Vivax/epidemiología , Parasitemia/diagnóstico , Parasitemia/epidemiología , Vitamina DRESUMEN
Malaria is an acute febrile infectious disease that represents an important public health problem in the Brazilian amazon region. The present study described the socio-epidemiological and spatial characteristics of malaria in a population from the Tapajós mining areas, Pará, Brazilian Amazon. A cross-sectional study, including individuals from Itaituba city, an area under mining activity influence, was conducted. The geographic coordinates were obtained in the field using the Global Positioning System (GPS) Garmin 78csx; for spatial analysis, we used the Kernel Density Estimator with the application of scanning statistics with the SaTScan software. Of the 908 individuals, 311 were positive for malaria. Most of the malaria cases were associated with male individuals, gold miners and with a monthly income of 4-6 salaries. Binary logistic regression analysis demonstrated that gold miners were nearly five times more likely to acquire malaria. In addition, a context of risk for sexually transmitted infections, substance abuse and poor support conditions was observed, worsening the healthcare scenario in this endemic area for malaria. The spatial distribution of malaria cases is irregular in the municipality with hotspot areas located in the Amana Flona that coincide with areas of illegal mining and high human mobility. Finally, the presented socio-epidemiological and spatial distribution data may aid in the development of more effective control measures for malaria in the area.
Asunto(s)
Malaria , Mineros , Brasil/epidemiología , Estudios Transversales , Humanos , Malaria/epidemiología , Masculino , MineríaRESUMEN
BACKGROUND: Outbreaks of Chagas disease (CD) by foodborne transmission is a problem related to deforestation, exposing people to triatomines infected by T. cruzi, in the Amazon region. Once involving long-time follow-up, the treatment efficacy of the CD during its acute phase is still unknown. The authors aim to describe the clinical and epidemiologic profile of children and adolescents with CD, as well as treatment and cardiac involvement during the follow-up. Methods: A descriptive cohort study was conducted from 1998 to 2013 among children and adolescents up to 18 years-old with confirmed diagnosis of CD. All participants met the criteria of CD in the acute phase. Results: A total of 126 outpatients were included and received treatment and follow-up examinations during a medium period of 10.9 years/person. Most of them (68.3%) had their diagnosis established during oral transmission outbreaks. The diagnostic method with the most positive results rate (80.9%) was the IgM class anti-T. cruzi antibody test as an acute phase marker, followed by the thick blood smears (60.8%). Acute myopericarditis was demonstrated in 18.2% of the patients, most of them with favorable evolution, though 2.4% (3/126) persisted with cardiac injury observed at the end point of the follow-up. Conclusions: Antibodies against T. cruzi persisted in 54.8% of sera from the patients without prognostic correlation with cardiac involvement. Precocious treatment can decrease potential cardiac complications and assure good treatment response, especially for inhabitants living in areas with difficult accessibility.
RESUMEN
INTRODUCTION: Mutations in the propeller domain of the Plasmodium falciparum kelch13 (k13) gene are associated with artemisinin resistance. METHODS: We developed a PCR protocol to sequence the pfk13 gene and determined its sequence in a batch of 50 samples collected from 2003 to 2016 in Brazil. RESULTS: We identified 1 K189T substitution located outside the propeller domain of the PfK13 protein in 36% of samples. CONCLUSIONS: Although the sample size is relatively small, these results suggest that P. falciparum artemisinin-resistant mutants do not exist in Brazil, thereby supporting the continuation of current treatment programs based on artemisinin-based combination therapy.
Asunto(s)
Artemisininas/farmacología , Resistencia a Medicamentos/genética , Malaria Falciparum/parasitología , Mutación/genética , Plasmodium falciparum/genética , Proteínas Protozoarias/genética , Genotipo , Humanos , Fenotipo , Plasmodium falciparum/efectos de los fármacosRESUMEN
Abstract INTRODUCTION Mutations in the propeller domain of the Plasmodium falciparum kelch13 (k13) gene are associated with artemisinin resistance. METHODS: We developed a PCR protocol to sequence the pfk13 gene and determined its sequence in a batch of 50 samples collected from 2003 to 2016 in Brazil. RESULTS: We identified 1 K189T substitution located outside the propeller domain of the PfK13 protein in 36% of samples. CONCLUSIONS: Although the sample size is relatively small, these results suggest that P. falciparum artemisinin-resistant mutants do not exist in Brazil, thereby supporting the continuation of current treatment programs based on artemisinin-based combination therapy.
Asunto(s)
Humanos , Plasmodium falciparum/genética , Resistencia a Medicamentos/genética , Proteínas Protozoarias/genética , Malaria Falciparum/parasitología , Artemisininas/farmacología , Mutación/genética , Fenotipo , Plasmodium falciparum/efectos de los fármacos , GenotipoRESUMEN
Children and adolescents are at great risk for developing iron deficiency anaemia worldwide. In the tropical areas, malaria and intestinal parasites may also play an important role in anaemia pathogenesis. This study aimed at evaluating clinical and immunological aspects of anaemia in children and adolescents with Plasmodium vivax malaria, in the Pará State, Brazil. A longitudinal study was performed in two Reference Centers for malaria diagnosis in the Brazilian Amazon in children and adolescents with malaria (nâ¯=â¯81), as compared to a control group (nâ¯=â¯40). Patients had blood drawn three times [before treatment (D0), after treatment (D7) and at the first cure control (D30)] and hemogram, autoantibody analysis (anticardiolipin, antibodies against normal RBC membrane components) and cytokine studies (TNF and IL-10) were performed. Stool samples were collected for a parasitological examination. Malaria patients had a 2.7-fold greater chance of anaemia than the control group. At D0, 66.1% of the patients had mild anaemia, 30.5% had moderate and 3.5% had severe anaemia. Positivity to intestinal helminths and/or protozoa at stool examinations had no influence on anaemia. Patients had significantly lower levels of plasmatic TNF than control individuals at D0. Low TNF levels were more prevalent among patients with moderate/severe anaemia than in those with mild anaemia and among anaemic patients than in anaemic controls. TNF levels were positively correlated with the haemoglobin rates and negatively correlated with the interval time elapsed between the onset of symptoms and diagnosis. Both plasma TNF levels and haemoglobin rates increased during the follow-up period. The IL-10 levels were lower in patients than in the controls at day 0 and decreased thereafter up to the end of treatment. Only the anti-anticardiolipin autoantibodies were associated with moderate/severe anaemia and, possibly by reacting with the parasite glycosylphosphatidylinositol (a powerful stimulator of TNF production), may have indirectly contributed to decrease the TNF levels, which could be involved in the malarial vivax anaemia of these children and adolescents. More studies addressing this issue are necessary to confirm these findings and to add more information on the multifactorial pathogenesis of the malarial anaemia.
Asunto(s)
Anemia/etiología , Malaria Vivax/complicaciones , Adolescente , Adulto , Anemia/inmunología , Animales , Niño , Preescolar , Femenino , Humanos , Interleucina-10/sangre , Estudios Longitudinales , Masculino , Factor de Necrosis Tumoral alfa/sangre , Adulto JovenRESUMEN
Malaria remains a major public health problem in Brazil where Plasmodium vivax is the predominant species, responsible for 82% of registered cases in 2013. Though benign, P. vivax infection may sometimes evolve with complications and a fatal outcome. Here, we report a severe case of P. vivax malaria in a 35-year-old Brazilian man from a malaria endemic area, who presented with reversible myocarditis.
Asunto(s)
Adulto , Humanos , Masculino , Malaria Vivax/complicaciones , Miocarditis/parasitología , Malaria Vivax/diagnóstico , Miocarditis/diagnósticoRESUMEN
Objetivo: determinar os níveis de glutationa reduzida em pacientes com malária por Plasmodium vivax não complicada no decorrer do tratamento com cloroquina e primaquina. Método: estudo quantitativo longitudinal de casos em 62 sujeitos do sexo masculino com malária por Plasmodium vivax no estado do Pará de dezembro de 2010 a dezembro de 2012. A glutationa reduzida foi determinada por espectrofotometria visível, que baseou-se na sua capacidade de reduzir ácido -5,5-ditiobis-2-nitrobenzóico (DTNB) e ácido nitrobenzóico (TNB). Resultado: o nivel médio de glutationa reduzida em pacientes com malária (2,03+-1, rumol/ml) foi significativamente inferior aquele de voluntários saudáveis (3,42 +- 1,36 umol/ml). No decorrer do tratamento, houve diminuição significativa dos níveis de glutationa reduzida> Conclusão: Os níveis de glutationa reduzida em pacientes com malária por P. vivax antes da introdução da quimioterapia, foram significativamente inferiores aqueles de voluntários saudáveis pareados por idade. A administração de antimaláricos foi acompanhada pela redução dos níveis de glutationa reduzida.
Objective: determine the reduced glutathione levels in patients with uncomplicated malaria by Plasmodium vivax during the treatment with chloroquine and primaquine. Method: A longitudinal quantitative
RESUMEN
Malaria remains a major public health problem in Brazil where Plasmodium vivax is the predominant species, responsible for 82% of registered cases in 2013. Though benign, P. vivax infection may sometimes evolve with complications and a fatal outcome. Here, we report a severe case of P. vivax malaria in a 35-year-old Brazilian man from a malaria endemic area, who presented with reversible myocarditis.
Asunto(s)
Malaria Vivax/complicaciones , Miocarditis/parasitología , Adulto , Humanos , Malaria Vivax/diagnóstico , Masculino , Miocarditis/diagnósticoRESUMEN
PURPOSE: To investigate changes in multifocal electroretinography (mfERG) parameters associated with high dose chloroquine therapy for treatment of malaria in the Amazonia region of Brazil. METHODS: Forty-eight subjects who had received chloroquine treatment for single or multiple malaria infections with a cumulative dose ranging from 1,050 to 27,000mg were included. The control group consisted of 37 healthy aged-matched subjects. Data was collected on amplitude and implicit time of the N1, P1 and N2 waves in the central macular hexagon (R1) and in five concentric rings at different retinal eccentricities (R2-R6). RESULTS: No significant difference was observed in any mfERG parameter between chloroquine treated patients and control subjects. A comparison with previous data obtained from patients with rheumatologic disorders in the same region of Brazil who had received larger cumulative doses of chloroquine and had displayed mfERG changes, indicated that retinal toxicity seems to be dependent on cumulative dose. CONCLUSION: Lack of mfERG changes in the current study suggests that intensive high dose chloroquine therapy for treatment of malaria is not associated with retinal toxicity.
RESUMEN
Objetivo: apresentação de um caso de síndrome nefrótica por malária falciparum. Relato decaso: escolar, 8 anos, sexo feminino, admitida no Hospital Municipal de Tailândia, Pará, comquadro de febre alta, seguida de surgimento de edema, urina escura e oligúria.. Evoluiu comanúria e foi transferida para a Fundação Santa de Misericórdia do Pará (FSCM-PA), onderecebeu diagnóstico de síndrome nefrótica secundária à malária por Plasmodium falciparum,com base em dados de anamnese, exame físico e exames complementares. A paciente obteveboa resposta clínica e parasitológica com a terapêutica antimalárica, recebendo alta hospitalarpara controle no Programa de Ensaios Clínicos em Malária do Instituto Evandro Chagas eAmbulatório de Nefrologia. Considerações finais: o acometimento renal é uma dascomplicações graves da malária com possível evolução para insuficiência renal aguda (IRA), eque pode ser fatal. Desenvolvimento de estratégias preventivas de combate aos distúrbios renaisassociados à malária requer conhecimento dos aspectos clínicos e epidemiológicos da doença,diagnóstico precoce e correto, além de terapêutica antimalárica.
Objective: presentation of nephrotic syndrome case due to falciparum malaria. Case report:school child, 8 years old, female, admitted at Municipal Hospital of Tailândia, Pará, with historyof fever, edema, dark urine and oliguria. Because the patient evolved with anuria, she wastransferred to Fundação Santa Casa de Misericórdia do Pará (FSCM-PA), where she wasdiagnosed with nephrotic syndrome secondary to Plasmodium falciparum malaria, based onanamnesis, physical examination, and laboratory exams. The patient had clinical andparasitological response to antimalarial therapy, being discharged to control at Clinical EssayMalaria Program at Evandro Chagas Institute and in a Nephrology Outpatient Unit. Finalconsideration: renal involvement is one of the serious complications of malaria. It can progressto acute renal failure (ARF), and may be fatal. Development of preventive strategies againstkidney disorders due to malaria infection requires knowledge of epidemiological and clinicalfeatures of the disease, accurate and prompt diagnosis and antimalarial therapy.
RESUMEN
No Brasil, a malária é endêmica na Região Amazônica, onde ocorrem mais de 99 por cento dos registros da doença, que é determinada pelo Plasmodium vivax em 84,4 por cento dos casos. Segundo dados do Ministério da Saúde do Brasil, em 2008, quase a metade (47,8 por cento) dos casos de malária notificados no país ocorreu em crianças e adolescentes salientando a importância do conhecimento das particularidades clínicas, laboratoriais e imunológicas da malária nessa faixa etária, particularmente sobre a anemia, um dos sinais cardinais da doença. Assim, foram avaliadas 81 crianças e adolescentes com malária vivax e 40 indivíduos do grupo controle, recrutados no Programa de Ensaios Clínicos em Malária do Instituto Evandro Chagas (Balem/Pará) e no Serviço de Diagnóstico de Malária, no município de Augusto Correa (Pará), no período de outubro de 2002 a agosto de 2005. hemograma e outros parâmetros hematológios, dosagem plasmática de citosinas e de anticorpos anti-P. vivax, anticardiolipina e antimembrana de eritrócitos (teste de antiglobulina direto e ELISA) foram realizados no primeiro dia de atendimento (D0), ao final do tratamento (D7) e no primeiro controle de cura (D30). Procedeu-se também ao rastreamento de doença falciforme e deficiência de Glicose 6 fosfato desidrogenase (G6PD), dosagem de ferritina sérica e exame parasitológico de fezes.A pesquisa do plasmódico em gota espessa foi realizada diariamente até que fossem obtidas duas lâminas negativas consecutivas. Autoctonia foi observada em 77,8 por cento dos casos de malária. Houve distribuição semelhante entre os gêneros e predomínio em adolescentes. A maioria era eutrófica. Para 43,2 por cento dos pacientes tratava-se do primeiro episódio da doença. A parasiemia média foi de 6.543 parasitas/mm³, tendo o clearance da parasitemia ocorrido no quarto dia de tratamento em 92,6 por centol dos casos. Nos pacientes com primoinfecção, a parasitemia foi maior do que naqueles com passado de maçaria. Estes pacientes também apresentaram significativo retardo no clearance da parasitemia. Os pacientes apresentaram contagens menores de leucócitos, que estavam correlacionados positivamente com a parasitemia e com a presença de anticorpos IgG e IgM, no momento do diagnóstico. Houve também uma diminuição no número de plaquetas, que estiveram negativamente correlacionadas à parasitemia. Observou-se correlação, inversa, entre número de reticulócitos e taxa de hemoglobina, no inicio e fim do tratamento e, direta, entre os níveis de ferritina sérica (significativamente maiores nos pacientes primoinfectados) e parasitemia. De forma surpreendente e ao contrário do referido em outros estudos, foram observados níveis plasmáticos de fator de necrose tumoral (TNF) menores nos pacientes do que no grupo controle. Os níveis, baixos em D0, estavam, de forma curiosa, correlacionados positivamente com a hemoglobina e negativamente com o tempo de diagnóstico e se elevaram significativamente até D30. A Interleucina-10 (IL-10), inversamente elevada em D0, mostrou uma correlação positiva com a parasitemia e esteve associada à presença de anticorpos IgM (mas não IgG) anti-P. vivax, antes de diminuir e atingir valores normais em D30.Autoanticorpos antieritrocíticos avaliados por ELISA declinaram mais rapidamente do que os revelados pelo teste e antiglobulina direto e do que os anticardiolipina. Além de 2,7 vezes mais chances de apresentar anemia, os pacientes tiveram significativamente mais anemia moderada/grave. A anemia esteve associada ao retrato diagnóstico e à demora de desaparecimento da parasitemia, mas não se mostrou associada a presença de anticorpos anti-P. vivax, à presença de autoanticorpos antimembrana de eritrócitos e nem a fatores como deficiência de G6PD, traço falciforme, desnutrição e parasitose intestinal. A anemia também esteve associada a maiores concentrações de IL-10 e à presença de anticorpos anticardiolipina, neste caso, somente para anemia moderada/grave. A associação com o TNF foi inversa, sendo os níveis supreendentemente menores no grupo de anêmicos, particularmente naqueles com anemia moderada/grave. Á luz das variáveis estudadas, que compuseram o quadro clínico epidemiológico, imunológico e laboratorial, em particular os eventos relacionados à anemia nestes pacientes commalária vivax, enfatiza-se a necessidade de pesquisas complementares na Amazônia Brasileira envolvendo maior número de crianças e adolescentes com malária, visando a confirmação dos resultados obtidos.
Asunto(s)
Anemia , Informes de Casos , Ensayos Clínicos como Asunto , Malaria , Plasmodium vivaxRESUMEN
The mechanisms of malarial anemia induction are poorly understood, but cytokines and autoantibodies are considered to play important roles. This work aimed at evaluating the degree of anemia and the plasmatic profile of the cytokines tumor necrosis factor alpha (TNF-alpha), gamma interferon (IFN-gamma), interleukin-12 (IL-12), migration inhibitory factor (MIF), and IL-10 and the monocyte chemotactic protein-1 (MCP-1) chemokine, as well as evaluating the presence of antibodies directed to components of the normal erythrocyte membrane and to cardiolipin in individuals with malaria from the Brazilian Amazon. No difference was observed in the frequency of anemia between patients infected by Plasmodium vivax and those infected by Plasmodium falciparum, and there was no relationship between the levels of parasitemia and the manifestations of anemia in P. vivax and P. falciparum patients. Significant increases in the concentrations of TNF-alpha, IFN-gamma, MIF, and MCP-1 were observed in patients with P. falciparum and P. vivax malaria, whereas the concentrations of IL-10 was increased only in patients with P. vivax infection. Higher concentrations of IL-12 and IL-10 were observed in the P. falciparum anemic patients, while for TNF-alpha this profile was observed in the nonanemic ones. P. vivax-infected and P. falciparum-infected patients with positive immunoglobulin M (IgM) or IgM and IgG responses, respectively, against blood-stage forms of the parasites had significantly lower hemoglobin levels than did those with negative responses. There was no correlation between the presence of anti-erythrocyte and anti-cardiolipin antibodies and the presence or intensity of the anemia. Our data suggest that in areas of low endemicity and unstable transmission of malaria, P. vivax and P. falciparum infections present similar characteristics in terms of the induction of anemia and cytokine responses.
Asunto(s)
Anemia/inmunología , Anemia/parasitología , Citocinas/inmunología , Malaria Falciparum/sangre , Malaria Falciparum/inmunología , Malaria Vivax/sangre , Malaria Vivax/inmunología , Adolescente , Adulto , Anticuerpos Antiprotozoarios/biosíntesis , Anticuerpos Antiprotozoarios/inmunología , Formación de Anticuerpos , Autoanticuerpos/biosíntesis , Autoanticuerpos/sangre , Autoanticuerpos/inmunología , Brasil , Niño , Citocinas/sangre , Femenino , Humanos , MasculinoRESUMEN
Avaliar a relação entre o FNT-α, a gravidade daapresentaçمo clيnica e a trombocitopenia, além da freqüênciado FNT2 e sua influência sobre os nيveis da citocina. Materiale Métodos: Foram avaliados pacientes primoinfectados peloP. vivax, ³ 15 anos, provenientes de Belém, Parل, com sintomashل £ 21 dias, atendidos e acompanhados clinicamente noInstituto Evandro Chagas (IEC) ou hospitalizados. A parasitemiafoi quantificada todos os dias até a negativaçمo. Adotou-se acloroquina e a primaquina por via oral, durante sete dias,como tratamento. Amostras sanguيneas foram coletadas emD0 e D7 para anلlises hematolَgicas e bioquيmicas, tيtulos doFNT-α e a freqüência do FNT2. Os programas Biostat 2.0 eExcel-Windows foram utilizados para as anلlises estatيsticasdas diferenças e das correlaçُes entre os parâmetros obtidos.Resultados: Oitenta e três pacientes foram atendidos eacompanhados clinicamente no D0, D1, D2, D3 e D7, defevereiro/2002 a março/2003. O FNT-α se correlacionoupositivamente e significativamente com a parasitemia (rs =0,33; p < 0,01) e com os escores clيnicos (rs = 0,48; p = 0,0001),porém negativamente com as plaquetas (rs = -0,48; p < 0,001)em D0. Os nيveis elevados de FNT-a foram responsلveis pelaintensidade das manifestaçُes clيnicas e pela trombocitopenianestes pacientes, porém o FNT2 nمo produziu tيtulos altos dacitocina. Conseqüentemente, tيtulos elevados de FNT-a forambenéficos na maioria dos casos, a plaquetopenia é um sinalde gravidade e outros fatores genéticos foram responsلveispelos nيveis elevados dessa citocina nesta amostra...
Evaluate the relationship between the TNF-a, theseverity of clinical presentation, the thrombocytopenia, thefrequency of TNF2 and its influence over cytokine levels.Material e Methods: We evaluated patients with first episodeof vivax malaria, ³ 15 years, with disease duration £ 21 days,coming from the city of Belém, Parل, attended at the InstitutoEvandro Chagas (IEC) or hospitalized. The parasitemia wasquantified every day till the negativation. The adoptedtreatment was cloroquine and primaquine PO, during sevendays. Blood samples were collected at D0 and D7 to realizequantification of hematological and biochemical parameters,TNF-a titles and TNF2 frequency. The programs Biostat 2.0and Excel for Windows were applied to analyze the differencesand correlations between the parameters. Results: Eighty threepatients were attended and accompanied clinically at D0, D1,D2, D3 and D7, from february/2002 till march/2003. TheTNF-a level correlated positively and significantly withparasitemia (rs = 0.33, p < 0.01) and clinical scores (rs = 0.48,p = 0.0001), but negatively with the platelets (rs = -0.48, p <0.0001) at D0. Consequently, high titles of TNF-a levels werebeneficial to the majority of the cases; the thrombocytopeniais a signal of severity, and others genetic factors were responsiblefor the high levels of this cytokine and phenotypicmanifestations on this sample...
Asunto(s)
Humanos , Masculino , Femenino , Malaria Vivax , TrombocitopeniaRESUMEN
Objetivo: avaliar a resposta de anticorpos IgG anti-P vivax (IgG anti-PV) e suas subclasses citofílicas (IgG1 e IgG3) e não citofílicas (IgG2), em 34 crianças com malária por P. vivax, de 0 a 15 anos de idade. Métodos: os níveis de anticorpos IgG foram mensurados pela técnica de imunofluorescência indireta, durante a fase aguda e de controle de cura. Os pacientes foram distribuídos em dois grupos, de priminfectados e pacientes com história de malária anterior. Os níveis de anticorpos no dia do ínicio do tratamento (ou dia zero) e no último dia de tratamento (ou D7) foram comparsdos (teste t de Student) e correlacionados com a parasitemia assexuada nos dois grupos (Correlação de Spearm). Resultados e conclusões: foi observado aumento inicial significativo dos títulos de IgG anti-PV no início e no final do tratamento. As médias geométricas dos títulos de subclasses de IgG anti PV encontradas nos pacientes com história prévia de malária foram IgG1 (806,35)>IgG3(28,28)>IgG2(20). Nos pacientes priminfectados as respostas obtidas foram IgG1(709,21)>IgG3(39,3)>IgG2(10,7). Não ocorreu associação entre parasitemia assexuada e títulos de IgG anti PV no primeiro dia de tratamento. Houve predominância de anticorpos citofílicos (IgG1>IgG3) sobre os não citofílicos